On April 1, 2026, Raymond James analyst John Ransom upgraded UnitedHealth Group (UNH) from a "Market Perform" to an "Outperform" rating. The analyst also announced a new price target of $330 USD for the stock. This marks a significant change in sentiment towards UNH by Raymond James.
Historically, UnitedHealth Group UNH has seen various analyst actions over the past few months:
- On February 5, 2026, Mizuho's Ann Hynes maintained an "Outperform" rating but lowered the price target from $430 to $350 USD.
- On February 2, 2026, JP Morgan's Lisa Gill maintained an "Overweight" rating, lowering the price target from $425 to $389 USD.
- Also on February 2, 2026, Truist Securities' David Macdonald maintained a "Buy" rating and decreased the price target from $410 to $370 USD.
- On January 30, 2026, Wells Fargo's Stephen Baxter maintained an "Overweight" rating while dropping the price target from $400 to $370 USD.
- On January 30, 2026, Barclays' Andrew Mok maintained an "Overweight" rating, adjusting the price target down from $391 to $327 USD.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.